16 May 2025
16 May 2025
The FDA approved 19 biosimilars in 2024, a sharp jump from the five greenlit by the agency in 2023.
The FDA has approved MSD’s Welireg for rare adrenal tumours, and AbbVie’s Emrelis for treating c-Met+ lung cancer patients.
AI is now used throughout clinical trials, from recruitment to analysis – but are regulators keeping up?
The new drug application was supported by positive interim data from the APeX-P trial.
The Milan Cell and Gene Center of Excellence at AGC Biologics will produce LVV material for Treg cell therapy candidates.
Proceeds from the round will be channelled into progressing the company's clinical-stage pipeline.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
